A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects
A Multicenter, Randomized, Double-Blind Study to Compare the Effects of VI-0521,Phentermine, and Placebo on Ambulatory Blood Pressure in Overweight or Obese Subjects
Sponsor: VIVUS LLC
Listed as NCT05215418, this PHASE4 trial focuses on Blood Pressure and remains completed. Sponsored by VIVUS LLC, it has been updated 15 times since 2022, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jul 2024 — Aug 2024 [monthly]
Completed PHASE4
-
May 2024 — Jul 2024 [monthly]
Completed PHASE4
▶ Show 10 earlier versions
-
Oct 2023 — May 2024 [monthly]
Completed PHASE4
-
Jun 2023 — Oct 2023 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
May 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE4
-
Feb 2023 — May 2023 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2023 — Feb 2023 [monthly]
Recruiting PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Recruiting PHASE4
-
Nov 2022 — Dec 2022 [monthly]
Recruiting PHASE4
-
Sep 2022 — Nov 2022 [monthly]
Recruiting PHASE4
-
Apr 2022 — Sep 2022 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2022 — Apr 2022 [monthly]
Not Yet Recruiting PHASE4
First recorded
Jan 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VIVUS LLC
For direct contact, visit the study record on ClinicalTrials.gov .